Polymers in Drug Delivery-State of the Art and Future Trends

被引:97
作者
Grund, Stefan [1 ]
Bauer, Marius [1 ]
Fischer, Dagmar [1 ]
机构
[1] Univ Jena, Inst Pharm, Dept Pharmaceut Technol, D-07745 Jena, Germany
关键词
WATER-SOLUBLE POLYMERS; IN-VITRO CYTOTOXICITY; TRIGGERED INTRACELLULAR ACTIVATION; ACCELERATED BLOOD CLEARANCE; BLOCK-COPOLYMER MICELLES; TUMOR-TARGETED DELIVERY; PHASE-II TRIAL; GENE DELIVERY; CONTROLLED-RELEASE; POLYETHYLENE-GLYCOL;
D O I
10.1002/adem.201080088
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Advances in biotechnology, proteomics, and genomics, as well as the deeper understanding of the molecular and cellular bases of pathophysiological states, have allowed the development of novel drugs such as proteins, peptides, and nucleic acids as therapeutic strategies of the future. Their application, however, requires sophisticated drug delivery systems which can be used to alter the pharmacokinetics and release characteristics of drugs, and to increase tissue specificity and biocompatibility. In this context, polymers provide the most promising avenue in drug release control due to their favorable, adjustable characteristics, and possibilities for further modification. Advances in the biomedical sciences have had a significant impact on the design and development of new and intelligent drug delivery systems for more controlled and targeted drug application. This review summarizes the status quo of polymer use for drug delivery with a special focus on structure-property relationships and gives overviews of various polymers, the relevant parameters in drug delivery and the most promising trends in the future.
引用
收藏
页码:B61 / B87
页数:27
相关论文
共 384 条
[61]   Tailored delivery of active keratinocyte growth factor from biodegradable polymer formulations [J].
Cho, EJ ;
Tao, ZY ;
Tang, Y ;
Tehan, EC ;
Bright, FV ;
Hicks, WL ;
Gardella, JA ;
Hard, R .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 66A (02) :417-424
[62]   Tools to rapidly produce and screen biodegradable polymer and sol-gel-derived xerogel formulations [J].
Cho, EJ ;
Tao, ZY ;
Tang, Y ;
Tehan, EC ;
Bright, FV ;
Hicks, WL ;
Gardella, JA ;
Hard, R .
APPLIED SPECTROSCOPY, 2002, 56 (11) :1385-1389
[63]   Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles [J].
Cho, YW ;
Lee, J ;
Lee, SC ;
Huh, KM ;
Park, K .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (02) :249-257
[64]   IN-VITRO CYTOTOXICITY OF MACROMOLECULES IN DIFFERENT CELL-CULTURE SYSTEMS [J].
CHOKSAKULNIMITR, S ;
MASUDA, S ;
TOKUDA, H ;
TAKAKURA, Y ;
HASHIDA, M .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) :233-241
[65]   Long-term effects of polyacrylamide hydrogel on human breast tissue [J].
Christensen, LH ;
Breiting, VB ;
Aasted, A ;
Jorgensen, A ;
Kebuladze, I .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (06) :1883-1890
[66]   Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles [J].
Cirstoiu-Hapca, A. ;
Bossy-Nobs, L. ;
Buchegger, F. ;
Gurny, R. ;
Delie, F. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 331 (02) :190-196
[67]  
Coleman M.M., 1998, FUNDAMENTALS POLYM S
[68]  
COOPER PD, 1993, ACTIVATORS INHIBITOR
[69]  
COWSAR DR, 1985, METHOD ENZYMOL, V112, P101
[70]   Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers [J].
Crampton, Hannah L. ;
Simanek, Eric E. .
POLYMER INTERNATIONAL, 2007, 56 (04) :489-496